Conference

Contact us


Speaker Introduction

Kaixian Chen
Academician,Shanghai Institute of Materia Medica,Chinese Academy of Sciences

Hualiang Jiang

Jing Cheng
Academician of Chinese Academy of Engineering

Subject
The fourth generation of drug-eluting coronary stents

Junbo Ge

Subject
Technology Support and Medical Imaging Development

WANG Weiqi

Yongkui Sun

Subject
Artificial intelligence capsule gastroscope Robot

Zhaokun Li

Subject
Pathogens and Research and Development of New Drugs

Zihe Rao

Subject
Research Progress in the Non-clinical Safety Evaluation of Immunotherapeutic Drugs

Yan Huo
Director of Toxicology Department, National Center for Safety Evaluation of Drugs,National Institutes for Food and Drug Control

Subject
Integration and Quality Management of Human Genetic Resources in General Hospital Biobank

KANG Xiaonan
Executive director of Biobank

Subject
Informatics Challenges in the Precision Health Initiative

Kun Huang

Subject
A Case Study of Contamination Control in a Biopharmaceutical Manufacturing Plant

Michael Ahern
Head of School of Science & Computing, Technological University Dublin

Subject
Systems Biologics: The Next Therapeutic Revolution

Sachdev Sidhu
The Donnelly Centre, University of Toronto

Subject
Targeting oncogenic signaling pathways in precision oncology

Vladimir L. Katanaev
Full Professor in Translational Oncology, Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva

Subject
Considerations on Current LDT Development from Differences between China and Foreign Countries

WANG Hualiang

Subject
Orthopaedic Robot

Huiwu Li

LOU Jiatou

Subject
Health economics (HTA evaluation of medical devices)

Xiaohua Ying

Subject
Combining Machine Learning and Structural Modeling for Drug Discovery

CHE Jianwei
Lead Scientist, Dana-Farber Cancer Institute, Dept. of Cancer Biology, Harvard Medical School Present
Independent Consultant for drug discovery companies 2018/08-2019/01
Chief Technology Officer & Co-founder, M3 Bioinformatics & Technology, Inc. 2014/10-2018/10
Visiting scholar, Dept. of Chem. & Biochem., UCSD 2015/1-2019/01
Sr. Research Investigator (2009-2014), Research Investigator (2001-2009) 2001/01-2014/10
Genomics Institute of the Novartis Research Foundation

Subject
Applying deep learning and AI to drug discovery at MSD

Alan Cheng
默沙东研究实验室 计算与结构化学部主任

Subject
Human Genetic Resource Management Process and Governance – Sharing from MNC Perspective

FU Helen

Subject
China's Clinical Biobank /Human Genetic Resources Enter the Age of Standardization and Recognition

GAO Hengjun

Subject
“Shock and Kill” for HIV Cure

LIU Jian
Principal Scientist, Discovery Chemistry, Merck Sharp & Dohme

Wansheng Jerry Liu
Partner & Chair of China Practice, Fox Rothschild LLP

XIA Mingde

Subject
Signaling pathways in tumor and tumor immune environment: insights into novel mechanisms and therapeutic approaches

Jean ZHAO

Subject
Interpretation of Innovative Medical Device Approval and Listing Permit Holder Policy

LIN Feng

Subject
Smart Insulin — Glycoengineering Confers Glucose Responsivity on Insulin

Lin Yan
Principal Scientist, Merck & Co., Inc.

Subject
Haplotype Analysis and Its Application in Genetic Disease

LU Daru

WU Yusheng
Tetranov Pharmaceutical Co., LTD

Subject
Investment and Industry Trends in IVD Field

Beier Yao

Subject
Platform technology

Hongbing He

Subject
Innovation and Quality Evaluation for In Vitro Diagnostic Reagents

HUANG Jie

Subject
Mechanism of Antitumor Immunotherapy and its Prospect —— Discovery of Toripalimab (JS001)

Hui Feng

Subject
The Practical Exploration and normalization construction of biobanking of human genetic resources

YANG Yajun
Fudan University Associate professor ,School of Life Sciences

Subject
The Application of Superparamagnetic Particle Imaging (SPI) Technology in IVD

Yu Ge
CEO, Mars Sciences LLC
Yu Ge have been involved in research and development of new drug and medical diagnostics for almost 30 years. I’ve worked at several drug discovery companies in various R&D and leadership capacities. Currently, I serve as the CEO of Mars Sciences, a medical diagnostic company. In drug discovery, I worked mainly in 3 disease areas: cardiovascular, cancer, and diabetes, and took 5 compounds into clinical trials. I am an inventor/co-inventor on 67 patents and authored over 20 peer reviewed scientific papers. In medical diagnostics, I’ve led the company to successfully develop the world leading Superparamagnetic Particle Imaging (SPI) technology and build the world’s first diagnostic instrument based on SPI technology (SPI Analyzer). SPI Analyzer, HY-POC Chips, and Mobile Mars APP formed the basis of MARS Smart Diagnostic Platform, which is currently being commercialized.

Subject
Introduction of National Standard System of Chinese Biobanks And inter-laboratory comparison

ZHANG Xiaoyan
head of biobank National Engineering Center for Biochip at Shanghai

Subject
New Business and Research Models for Innovative Drug R & D

LI Jian

Subject
Application of Innovative Medical Device Consumables

XIE Jian

ZHANG Zhenbo

Subject
The novel revolutionary strategy to prevent cancer metastases

JIA Li
中组部“千人计划”特聘教授;福建省肿瘤转移药物干预重点实验室 主任

Subject
Accelerating Drug Discovery with Physics Based Modeling and Artificial

Jianxin Duan
德国Schrodinger公司 研究员

Subject
Agile Project Management and Operation Excellence in the New Age of Drug Development

John Sun
Global Program Lead, Novartis

Subject
Driving Clinical Strategy & Optimized Design with RWD and Clinical Patient-level Data

Meng Fu
Vice President of Clinical Development, 3D Medicine

PAN Boshen

Subject
Shanghai Malignant Tumor Clinical Biobank /Human Genetic Resources Alliance

SUN Menghong

Subject
Boehringer Ingelheim BioXcellenceTM, Bring Your Biologics to the Clinic and Market

WANG Bin

Subject
A novel therapy targeting a survival mechanism of cancer cells

ZENG Qingping

LI Jiyu

Li Mengjie

Xiaodong Chen
Senior Research Investigator, Drug Product Development Team Leader, Bristol-Myers Squibb

Subject
Innovation in Smart IVD

XU Jianxin

Subject
Patenting Antibody Based Inventions in The US

Puknys Erik
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

BEHAN John

Subject
Provide CRO Service For Chinese Biopharmaceutical Companies To Enter The Eurasian Market

Ternova IRINA

WANG Peijun

Subject
Using Artificial Intelligence in Patient Recruitment for Clinical Trials

Yaoping Ruan
Chief Data Scientist, LinkDoc 2018 – present,
RSM, Senior Manager, STSM, IBM Watson Health 2005 – 2018

Zhihua Xiao

Subject
Introduction To Experience Of International Multi-Center Cooperation In Moscow Scientific Research Oncological Institute Named After P. A. Herzen

Elena FILONENKO

Subject
Welcome to the Russian-Speaking World of Science. We are going to Help You Enter the Eurasian Market

SU Jing

Subject
Case Study: Medical-Engineering Interactive Projects Regrading Patient-Specific Additive Manufacturing Medical Device within MAH System

WANG Qi

Subject
Orthopedic joint localization

WENG Zixin

XU Jiaqi

Subject
Localization of Diagnostic Raw Materials:Opportunities and Challenges

Huaxing Zhu

Subject
Next-generation Diagnositcs with CRISPR

Jin Wang

LI Jianqing

Subject
Machine Learning for Data Analysis in Orthopaedics

LI Kang
Associate Professor, New Jersey Medical School, Rutgers University

Subject
Financing Project Release: Normal Temperature Cardioplegia for Cardiac Surgery

Merkin NIKOLAY

QIAN Jianguo

WANG Jianxin

Subject
The World’s First Integrated CT-linac

Zhong Ouyang

CHEN Li

Subject
Introduction To The Innovation Project Of The National University Of Belarus Science Park

Pavel BYCHKOUSKI

Subject
A novel therapy targeting a survival mechanism of cancer cells

ZENG Qingping
Founder and CEO of Fosun Orinove PharmaTech Inc

ZHANG Jingyi

ZHANG Lifang

Subject
The role of small molecules in targeted therapies for cancer_Current status and the future

ZHAO Xingdong
Fochon Pharmaceuticals

Subject
Presentation of the research achievements in the field of biomedicine by the National Academy of Sciences of Belarus

Elena ORLOVA

Subject
Development status and trend of digital medical equipment in China

CAI Kui

Subject
Full Solution on Companion Diagnostics for Precision Oncology

Guanshan Zhu

LEI Jifeng

LI Yixue

Maxwell Kirkby

WU Zhenping

Subject
PuE & startech united technological startups from China and Russia

Vladislav ZDORENKO

LI Xiaotian

LUO Jiali

Subject
Siberia Original Ecological Health Resources and Product Cooperation Project Released

Tatyana GOROKHOVSKAYA

Subject
Strategies to Enhance Effectiveness Of Antibody-Based Immuo-Modulators

Huang Haoyu

XU Ning

ZHU Hongguang

Subject
Target Protein Degradation in Drug Discovery

DAI Han

HU Qiyue

Subject
From Intrasac Coiling to Blood Flow Reconstruction----Revolution in The Treatment of Intracranial Aneurysms

LI Qiang

NI Jian

Subject
Strategy of Localization of Cardiac Pacemaker —— Made in China or Innovated in China?

ZHU Xiaoming

TOP